What is the Sundaram Multi Pap PE ratio today?
Sundaram Multi Pap's PE ratio is 12.6 at the previous close (₹1.05 a share): a market capitalisation of ₹49.8 crore divided by standalone net profit of ₹3.9 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹3.2 crore) it is 15.6.
What is the Sundaram Multi Pap debt to equity ratio?
Sundaram Multi Pap's debt-to-equity ratio was 0.22 on 31 March 2026: borrowings of ₹20 crore against total equity of ₹90.7 crore. A year earlier, on 31 March 2025, it was 0.29.
What is the Sundaram Multi Pap net worth?
Sundaram Multi Pap's net worth — shareholders' equity in its standalone balance sheet — was ₹90.7 crore on 31 March 2026, up 3.6% from ₹87.5 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹49.8 crore at the previous close.
What is the Sundaram Multi Pap PB ratio (price to book value)?
Sundaram Multi Pap's price-to-book (PB) ratio is 0.55 at the previous close: a market capitalisation of ₹49.8 crore divided by shareholders' equity (book value) of ₹90.7 crore on 31 March 2026. That is a book value of ₹1.91 per share against a share price of ₹1.05.
What is the Sundaram Multi Pap ROE and ROCE?
In FY26, Sundaram Multi Pap's return on equity (ROE) was 3.6% and its return on capital employed (ROCE) was 2.4%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −5.7% and ROCE −2.6%.
What is the Sundaram Multi Pap book value per share?
Sundaram Multi Pap's book value per share was ₹1.91 on 31 March 2026: shareholders' equity of ₹90.7 crore divided by the 47.39 crore shares in issue, up 3.6% from ₹1.85 a year earlier. The share price at the previous close was ₹1.05.
What is the Sundaram Multi Pap market cap?
Sundaram Multi Pap's market capitalisation was ₹49.8 crore at the previous close: 47.39 crore shares at ₹1.05 each.
Is Sundaram Multi Pap debt free?
No. Sundaram Multi Pap had borrowings of ₹20 crore on 31 March 2026 (standalone balance sheet), a debt-to-equity ratio of 0.22. Its cash and current investments were ₹20 lakh, so its net debt was ₹19.8 crore.
What is the Sundaram Multi Pap EPS?
Sundaram Multi Pap's basic earnings per share (EPS) were ₹0.07 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹0.08.
What is the Sundaram Multi Pap promoter holding?
Promoters held 31.11% of Sundaram Multi Pap on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
What is the Sundaram Multi Pap shareholding pattern?
On 30 September 2026, Sundaram Multi Pap's shares were held by promoters 31.11%, domestic institutions (DII) 0.05% and retail and other non-institutional investors 68.84%. Over the year, DII holding was unchanged.
What is the Sundaram Multi Pap free cash flow?
In FY26, Sundaram Multi Pap generated ₹2.2 crore of cash from operations and spent ₹4.7 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹6.9 crore. In FY25 it was ₹6.9 crore.
What are the Sundaram Multi Pap latest quarterly results?
Sundaram Multi Pap's latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: standalone net profit ₹32 lakh, against a loss of ₹44 lakh in Q1 FY26; revenue from operations ₹49.6 crore, up 22.0% year on year.
What is the Sundaram Multi Pap revenue and profit in FY26?
In FY26 (April 2025–March 2026), Sundaram Multi Pap's standalone net profit was ₹3.2 crore, against a loss of ₹5.1 crore in FY25, on revenue from operations of ₹137 crore (up 7.6%). Over three years, from FY23, net profit was up 22.8%.
Sundaram Multi Pap vs Linc: how do they compare?
In FY26, Sundaram Multi Pap earned net profit of ₹3.2 crore on revenue of ₹137 crore, against ₹36.6 crore on ₹532 crore for Linc. Sundaram Multi Pap's operating margin was 1.6% (Linc 8.0%) and its return on equity 3.6% (Linc 14.8%).
When are the Sundaram Multi Pap next results?
Sundaram Multi Pap has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
How does Sundaram Multi Pap compare with its peers?
On FY26 standalone figures, against Linc, Kokuyo Camlin and Flair Writing Industries: Sundaram Multi Pap's operating margin of 1.6% is the lowest of the four (Linc 8.0%, Kokuyo Camlin 4.5%, Flair Writing Industries 11.9%; peer average 8.1%); its return on equity of 3.6% is the lowest of the four (Linc 14.8%, Kokuyo Camlin 7.9%, Flair Writing Industries 11.2%; peer average 11.3%).
Standalone figures from the company's filings with NSE; prices are NSE closing prices.
